Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
GLP-1 drugs first helped people manage Type 2 diabetes. Today, doctors also use them widely for weight loss. Researchers are now exploring whether these medications could also affect breast cancer risk and outcomes. Early studies suggest that GLP-1 drugs may…
A new study published in The BMJ offers encouraging news for adults with type 2 diabetes and heart conditions. Researchers found that tirzepatide, the main ingredient in Mounjaro, may reduce the risk of major heart problems. The study suggests that…
Millions of people now take a GLP-1 drug like Ozempic, Wegovy, or Mounjaro. These drugs have helped people lose weight. They’ve also helped people manage type 2 diabetes. Many people say these medications gave them back control of their health.…
The arrival of GLP-1 medications has completely transformed the landscape of metabolic health and weight management. For years, patients relied on weekly injections to experience the fantastic benefits of treatments like semaglutide. The introduction of a daily oral formulation under…
If you recently started taking a weight-loss or diabetes medication like Ozempic, Wegovy, or Mounjaro, you might have noticed something a bit surprising. Your go-to snacks just do not taste the same anymore. A food you used to love might…
It is no secret that glucagon-like peptide-1 (GLP-1) receptor agonists have completely reshaped how we approach metabolic health. Today, physicians across the country are prescribing breakthrough treatments like Ozempic, Wegovy, and Mounjaro more than ever before. For millions of people…
More Americans than ever are taking GLP-1 medications for weight loss. The numbers are hard to ignore. A new Gallup survey found that 15% of U.S. adults have used one of these drugs at some point for weight loss. Right…
New survey data indicates that patient utilization of GLP-1 medications has reached an unprecedented peak. Eleven percent of adults now report the current use of a GLP-1 drug for weight reduction. This metric represents a significant increase from the 3…
Novo Nordisk’s oral diabetes pill, Rybelsus, is carving out its own space in the GLP-1 market. Unlike its injectable siblings, Ozempic and Wegovy, Rybelsus comes as a tablet. That single difference makes it appealing to people who simply don’t want…
For many patients navigating type 2 diabetes, the treatment journey has completely transformed over the past few years. We are living in a golden age of metabolic healthcare. Clinicians and patients now have access to incredibly effective tools that do…